Accuray up 15% after hours on FQ2 beat 
 Fiscal 2020 guidance: Revenue: $410M - 420M (unch); non-GAAP EBITDA: $21M - 26M from $19M - 24M (includes ~$1M expected loss from its JV in China).

Management does not believe that the coronavirus outbreak in China will affect the long-term demand for radiotherapy equipment there.